X

Courses


This program is designed to address the professional practice gaps in all six competencies including patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism and systems-based practice.  This program will provide updated information on the new guidelines and recommendations based on the most current research presented at the national American Association for the Study of Liver Disease Meeting, November 7-8, 2014 in Boston, MA, and will go a long way towards improving patient outcomes.

Advances are occurring at a rapid pace in the treatment of liver diseases.  These advances include new guidelines and recommendations for the treatment of viral hepatitis and hepatocellular cancer.  It is important for care providers to be made aware of these advances to provide quality, ethical and cost-effective care of patients with liver disease.

  • Provide participants with the knowledge to evaluate the impact of new strategies for screening of hepatitis B and hepatitis C
  • Participants will be able to understand the changing global epidemiology of HCV infection
  • Participants will better understand the strengths and limitations of recently approved therapeutic regimens
  • Participants will better understand the progression of liver disease and hepatocellular carcinoma
  • Participants will be able to provide better and cost effective screening work-ups for patients with chronic liver disease using appropriate screening methods:  liver biopsy, fibroscan, ultrasound, alpha-fetoprotein, computed tomography and/or magnetic resonance imaging
  • Participants will be able to identify the relevant immune-mediated events contributing to liver pathology and the progression of liver disease in a more timely fashion
  • Participants will better understand the need for early intervention and management in patients with liver disease, therefore preventing/reducing the progression of chronic liver disease by effective use of immunosuppressives, antiviral agents, bile salts therapies.

TARGET AUDIENCE 
Internists, Family Practitioners, Gastroenterologists, Hepatologists, Infectious Disease Physicians, Residents, and Fellows, Nurse Practitioners, and Physician Assistants

COURSE FEES
Webinars may be viewed Complimentary; however, registration is required. 

You may elect to view one or more of the webinars upon registration.
Session 1, September 10, 2014
Bruce R. Bacon, M.D.,
Director, Center for Abdominal Transplantation
James F. King MD Endowed Chair in Gastroenterology
Professor of Internal Medicine Saint Louis University School of Medicine

Session 2, January 6, 2014
Adrian M. Di Bisceglie, M.D.
President, American Association for the Study of Liver Diseases
Badeeh A. & Catherine V. Bander
Chair in Internal Medicine, Chairman and Professor of Internal
Medicine, Chief of Hepatology Saint Louis University School of Medicine

Session 3, March 10, 2015 ( Co-Presenters)
Alex S. Befeler, M.D.
Medical Director of Liver Transplantation
Professor of Internal Medicine Saint Louis University
School of Medicine

Mark A. Schnitzler, Ph.D.
Professor of Internal Medicine, Health Management
& Policy, School of Public Health, Saint Louis University

Accreditation

Saint Louis University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

American Medical Association

Saint Louis University designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 Nursing Approved for the Live Activity , June 17, 2015 ONLY

Saint Louis University School of Nursing is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.Midwest MSD Provider Approval # 118 - IINursing Contact Hours: 1.0



Privacy Notice/Grievance Policy & Procedure

Privacy Notice for Registrants of SLU CME/CE Activities
  • We do not sell or rent the information we have about you to anyone
  • We do not share your information with outside companies for the purpose of selling their products or services to you
  • We will use your email information to inform you of upcoming CME/CE activities approved by the SLU CME Program
  • You have the right to OPT-Out at any time when receiving invitations regarding upcoming CME/CE activities

Grievance Policy & Procedure

The monitoring and assessment of compliance with these standards and the SLU CME Program Mission is the responsibility of the CME Program Director in consultation with the CME Program Accrediting Director & CME Chairperson, and the Continuing Education Committee.

While Saint Louis University CME Program attempts to anticipate issues and assure fair treatment for all participants to conduct and experience valid and successful CME activities, there may be occasional issues which require intervention and/or action on the part of the CME Program. 

To register a complaint or grievance with the Saint Louis University CME Program:

Submit a written, detailed complaint or grievance to cme@slu.edu.

1.        Complaints will be reviewed by the Program Director and addressed or transferred to the appropriate level for review:

·          Answers and/or actions taken to rectify complaints will be documented and sent to those that provide contact information.

·          If appropriate, complaints will be reviewed at the CME Committee Meeting for members to discuss and find solutions to the area of complaint.

·          Compliance issues will automatically be moved up to the Accrediting Director for immediate review.

To submit concerns regarding compliance with accreditation requirements, a direct portal to the ACCME Complaint Form is provided on the Saint Louis University CME website, http://www.accme.org/accme-complaint-form.